Meridian Bioscience Inc. (NASDAQ:VIVO) Reported Basic Consolidated EPS Of $0.8531 For Period Ended 2015-09-30

0

The annual basic consolidated EPS for Meridian Bioscience Inc. (NASDAQ:VIVO) for the period ended 2015-09-30 was $0.8531. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-09-30 was $0.8531.

EPS from continuing operations

Coming to basic EPS from continuing operations, Meridian Bioscience Inc. (NASDAQ:VIVO) reported $0.8531 for the annual period ended 2015-09-30. Quarterly basic EPS from continuing operations for the three-month period ended 2015-09-30 stood at $0.8531.

EPS contribution from parent

For the annual period ended 2015-09-30, Meridian Bioscience Inc. (NASDAQ:VIVO) received basic EPS of $0.8531 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-09-30 was $0.8531.

Basic net EPS

For the annual period ended 2015-09-30, Meridian Bioscience Inc. (NASDAQ:VIVO) reported basic net EPS of $0.85. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-09-30 stood at $0.85.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-09-30 stood at $0.8459. For the quarter ended 2015-09-30, consolidated diluted EPS was $0.8459.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $0.8459 for the period ended 2015-09-30. Diluted EPS from continuing operations for the quarter ended 2015-09-30 was $0.8459.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-09-30 was $0.85. For the quarterly period ended 2015-09-30, net diluted EPS was $0.85.

Diluted EPS from parent

From the parent company, Meridian Bioscience Inc. (NASDAQ:VIVO) received diluted EPS of $0.8459 for the annual period ended 2015-09-30. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-09-30 was $0.8459.

Meridian Bioscience Inc. (NASDAQ:VIVO) posted net basic EPS reading of $0.85 for the annual period ended 2015-09-30. For the quarter, basic net EPS of $0.85 was for the quarter ended 2015-09-30.

Net diluted EPS for Meridian Bioscience Inc. (NASDAQ:VIVO) for the annual period ended 2015-09-30 was $0.85. The company also reported net diluted EPS reading of $0.85 for the quarter ended 2015-09-30.

The annual average basic shares outstanding for the period ended 2015-09-30 is 41.659 while for the quarter ended 2015-09-30 is 41.659.

The diluted shares outstanding for the fiscal year ended is 2015-09-30 is 42.012 while for the quarter ended 2015-09-30 is 42.012.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)